Cargando…

Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report

A 46-year-old Korean woman was diagnosed with stage III breast cancer and underwent 8 cycles of neoadjuvant chemotherapy, breast conservation surgery and adjuvant radiotherapy. However, the cancer recurred in the right upper lung (RUL) and the right pulmonary hilum after 8 months. The RUL nodule was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong-Hyun, Kim, Sung-Su, Seong, Shin, Kim, Nari, Han, Jae-Bok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361909/
https://www.ncbi.nlm.nih.gov/pubmed/25848354
http://dx.doi.org/10.1159/000375292
_version_ 1782361724541730816
author Lee, Dong-Hyun
Kim, Sung-Su
Seong, Shin
Kim, Nari
Han, Jae-Bok
author_facet Lee, Dong-Hyun
Kim, Sung-Su
Seong, Shin
Kim, Nari
Han, Jae-Bok
author_sort Lee, Dong-Hyun
collection PubMed
description A 46-year-old Korean woman was diagnosed with stage III breast cancer and underwent 8 cycles of neoadjuvant chemotherapy, breast conservation surgery and adjuvant radiotherapy. However, the cancer recurred in the right upper lung (RUL) and the right pulmonary hilum after 8 months. The RUL nodule was removed through a wedge resection, and the pathologic finding was revealed as a metastatic adenocarcinoma. Adjuvant chemotherapy was recommended, but she refused it because she feared adverse reactions to chemotherapy. Instead, Korean Medicine Therapy with intravenous wild ginseng pharmacopuncture (WGP), Cordyceps sinensis pharmacopuncture, Trichosanthes kirilowii pharmacopuncture, Euonymus alatus pharmacopuncture (EAP) and Astragalus membranaceus pharmacopuncture was started. After a month, the disease looked stable, but findings of newly occurring metastatic lymphadenopathies appeared on CT after 6 months. Salvage chemotherapy was recommended, but she also refused it. At this time, Prunella vulgaris pharmacopuncture was started. Finally, a complete resolution was confirmed on PET-CT after 5 months, and she has remained in stable condition for more than 6 months with WGP, EAP, a Soram nebulizer solution inhalation and the oral intake of Soramdan S and Hangamdan S.
format Online
Article
Text
id pubmed-4361909
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-43619092015-04-06 Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report Lee, Dong-Hyun Kim, Sung-Su Seong, Shin Kim, Nari Han, Jae-Bok Case Rep Oncol Published online: February, 2015 A 46-year-old Korean woman was diagnosed with stage III breast cancer and underwent 8 cycles of neoadjuvant chemotherapy, breast conservation surgery and adjuvant radiotherapy. However, the cancer recurred in the right upper lung (RUL) and the right pulmonary hilum after 8 months. The RUL nodule was removed through a wedge resection, and the pathologic finding was revealed as a metastatic adenocarcinoma. Adjuvant chemotherapy was recommended, but she refused it because she feared adverse reactions to chemotherapy. Instead, Korean Medicine Therapy with intravenous wild ginseng pharmacopuncture (WGP), Cordyceps sinensis pharmacopuncture, Trichosanthes kirilowii pharmacopuncture, Euonymus alatus pharmacopuncture (EAP) and Astragalus membranaceus pharmacopuncture was started. After a month, the disease looked stable, but findings of newly occurring metastatic lymphadenopathies appeared on CT after 6 months. Salvage chemotherapy was recommended, but she also refused it. At this time, Prunella vulgaris pharmacopuncture was started. Finally, a complete resolution was confirmed on PET-CT after 5 months, and she has remained in stable condition for more than 6 months with WGP, EAP, a Soram nebulizer solution inhalation and the oral intake of Soramdan S and Hangamdan S. S. Karger AG 2015-02-10 /pmc/articles/PMC4361909/ /pubmed/25848354 http://dx.doi.org/10.1159/000375292 Text en Copyright © 2015 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: February, 2015
Lee, Dong-Hyun
Kim, Sung-Su
Seong, Shin
Kim, Nari
Han, Jae-Bok
Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report
title Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report
title_full Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report
title_fullStr Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report
title_full_unstemmed Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report
title_short Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report
title_sort korean medicine therapy as a substitute for chemotherapy for metastatic breast cancer: a case report
topic Published online: February, 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361909/
https://www.ncbi.nlm.nih.gov/pubmed/25848354
http://dx.doi.org/10.1159/000375292
work_keys_str_mv AT leedonghyun koreanmedicinetherapyasasubstituteforchemotherapyformetastaticbreastcanceracasereport
AT kimsungsu koreanmedicinetherapyasasubstituteforchemotherapyformetastaticbreastcanceracasereport
AT seongshin koreanmedicinetherapyasasubstituteforchemotherapyformetastaticbreastcanceracasereport
AT kimnari koreanmedicinetherapyasasubstituteforchemotherapyformetastaticbreastcanceracasereport
AT hanjaebok koreanmedicinetherapyasasubstituteforchemotherapyformetastaticbreastcanceracasereport